Amgen(AMGN)

Leader#2 in Healthcare Tech

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI Drug Discovery
AMGN
Visit Website
Updated March 2026

Company Overview

About Amgen

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Business Model & Competitive Advantage

Amgen's portfolio spans oncology (Kyprolis, Blincyto, Lumakras), bone health (Prolia, Xgeva), cardiovascular (Repatha), inflammation (Otezla, Enbrel), rare diseases (Tepezza, Uplizna from Horizon), and general medicine (Aimovig for migraines). The company's biosimilars business is a growing revenue stream as it develops lower-cost alternatives to competitor biologics. Repatha (evolocumab), Amgen's PCSK9 inhibitor for cholesterol management, is among the fastest-growing products. Amgen faces patent cliffs on key products but has a robust pipeline with 30+ molecules in clinical development.

Competitive Landscape 2025–2026

Amgen is one of the most active adopters of AI in drug discovery. The company has built internal machine learning capabilities for protein structure prediction, molecule generation, and clinical trial optimization, with external partnerships supplementing internal R&D. Amgen trades on NASDAQ (AMGN) and is a component of the Dow Jones Industrial Average with a market cap of approximately $130B.

Revenue
$33400M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Market Leader

Amgen is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.

Enterprise Scale

With $33400M in revenue, Amgen operates at enterprise scale with proven market validation.

Top 3 Ranked

Ranked #2 in the Healthcare Tech category, consistently recognized for excellence.

Frequently Asked Questions

Not So Random Others

YouShift

Healthcare Tech
HealthtechManufacturing

YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple

Hermes Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Bucket Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Dusty Robotics

Infrastructure
B2bPlatformManufacturing

Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita

Compare Amgen with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Amgen

Claim This Profile

Are you from Amgen? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Amgen Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Amgen vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →